U.S. Markets closed
  • S&P 500

    4,704.54
    +15.87 (+0.34%)
     
  • Dow 30

    35,870.95
    -60.10 (-0.17%)
     
  • Nasdaq

    15,993.71
    +72.14 (+0.45%)
     
  • Russell 2000

    2,363.59
    -13.42 (-0.56%)
     
  • Gold

    1,861.20
    -0.20 (-0.01%)
     
  • Silver

    24.88
    -0.02 (-0.08%)
     
  • EUR/USD

    1.1369
    -0.0006 (-0.0568%)
     
  • 10-Yr Bond

    1.5890
    -0.0150 (-0.94%)
     
  • Vix

    17.59
    +0.48 (+2.81%)
     
  • GBP/USD

    1.3497
    -0.0003 (-0.0216%)
     
  • USD/JPY

    114.3040
    +0.0520 (+0.0455%)
     
  • BTC-USD

    54,029.69
    -358.79 (-0.66%)
     
  • CMC Crypto 200

    1,402.14
    -65.80 (-4.48%)
     
  • FTSE 100

    7,255.96
    -35.24 (-0.48%)
     
  • Nikkei 225

    29,683.09
    +84.43 (+0.29%)
     

Marcus & Millichap, Inc. Just Reported Earnings, And Analysts Cut Their Target Price

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Marcus & Millichap, Inc. (NYSE:MMI) defied analyst predictions to release its yearly results, which were ahead of market expectations. The company beat expectations with revenues of US$806m arriving 2.6% ahead of forecasts. Statutory earnings per share (EPS) were US$1.95, 2.1% ahead of estimates. Analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We thought readers would find it interesting to see analysts' latest (statutory) post-earnings forecasts for next year.

See our latest analysis for Marcus & Millichap

NYSE:MMI Past and Future Earnings, February 23rd 2020
NYSE:MMI Past and Future Earnings, February 23rd 2020

Taking into account the latest results, the most recent consensus for Marcus & Millichap from sole analyst is for revenues of US$851.0m in 2020, which is a credible 5.5% increase on its sales over the past 12 months. Statutory earnings per share are expected to accumulate 5.0% to US$2.05. In the lead-up to this report, analysts had been modelling revenues of US$831.5m and earnings per share (EPS) of US$2.05 in 2020. There doesn't appear to have been a major change in analyst sentiment following the results, other than the small lift in revenue estimates.

Even though revenue forecasts increased, the consensus price target 11% to US$39.00, perhaps suggesting that analysts have become more pessimistic about the lack of earnings growth.

Another way to assess these estimates is by comparing them to past performance, and seeing whether analysts are more or less bullish relative to other companies in the market. Next year brings more of the same, according to analysts, with revenue forecast to grow 5.5%, in line with its 5.6% annual growth over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenues grow 8.9% per year. So although Marcus & Millichap is expected to maintain its revenue growth rate, it's forecast to grow slower than the wider market.

The Bottom Line

The most important thing to take away is that there's been no major change in sentiment, with analysts reconfirming that earnings per share are expected to continue performing in line with their prior expectations. Fortunately, analysts also upgraded their revenue estimates, although our data indicates sales are expected to perform worse than the wider market. Analysts also downgraded their price target, suggesting that the latest news has led analysts to become more pessimistic about the intrinsic value of the business.

Even so, the longer term trajectory of the business is much more important for the value creation of shareholders. We have analyst estimates for Marcus & Millichap going out as far as 2021, and you can see them free on our platform here.

We also provide an overview of the Marcus & Millichap Board and CEO remuneration and length of tenure at the company, and whether insiders have been buying the stock, here.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.